A surgical team from the School of Medicine recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.
Virginia McKay, a research assistant professor at the Brown School, is leading a $3.5 million project to test whether an effort to improve cancer treatment for children in Latin America is sustainable over the long term.
Maggie Mullen, MD, an assistant professor of obstetrics and gynecology at the School of Medicine, has been selected to participate in the National Cancer Institute’s 2023 Early-Stage Surgeon Scientist Program Cohort of Surgeon Scientists.
A new study in mice led by School of Medicine researchers shows how prostate cancer creates its own hormonal fuel supply in response to anti-testosterone therapy. The study further suggests a strategy to block this process and potentially improve therapy options.
Researchers led by Gary J. Patti in Arts & Sciences established a method to watch what nutrients are used at which rates spatially throughout a tumor. The new approach offers clues for potential treatment strategies.
Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine is launching a prostate cancer screening initiative along with an educational campaign in the St. Louis region to address racial disparities in prostate cancer.
The School of Medicine has received two grants totaling $22.5 million to help lead national efforts to understand how DNA changes create differences in genomes across tissues within the same person.
Repeated mammograms contain data on changes in breast density over time that could help identify women at high risk of breast cancer and even reveal which breast is likely to be affected, according to a study by researchers at the School of Medicine.
Researchers at the School of Medicine have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. The incidence of colorectal cancer is rising in people under 50, making it important to recognize such signs.
Quing Zhu, at the McKelvey School of Engineering, and Matthew Mutch, MD, at the School of Medicine, have been working together to develop a new imaging technology that can help doctors determine which colorectal cancer patients’ treatments have been successful, helping some to avoid surgery. Their efforts received a $1.75 million National Institutes of Health (NIH) grant.